| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $63.3M | +3.1% |
| SG&A Expense | $22.9M | +8.3% |
| Operating Income | -$84.6M | -4.1% |
| Interest Expense | $6.2M | +42.6% |
| Income Tax | $0 | — |
| Net Income | -$12.0M | +54.8% |
| EPS (Basic) | -$0.12 | +81.8% |
| EPS (Diluted) | -$0.12 | +81.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $149.8M | -31.1% |
| Short-term Investments | $2.1M | -73.7% |
| Accounts Receivable | $31K | -82.4% |
| Current Assets | $154.2M | -32.8% |
| Total Assets | $204.3M | -28.7% |
| Current Liabilities | $19.6M | +77.2% |
| Total Liabilities | $87.4M | -46.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$71.1M | +12.4% |
| Capital Expenditures | $1.0M | +376.4% |
| Investing Cash Flow | $4.8M | +158.9% |
| Financing Cash Flow | -$1.4M | -100.5% |
| Free Cash Flow | -$72.2M | +11.3% |
| Stockholders' Equity |
| $116.9M |
| -4.3% |